How to Choose a Local Authorized Representative for Medical Device Registration in Indonesia?

How to Choose a Local Authorized Representative for Medical Device Registration in Indonesia?

Direct answer: In Indonesia, a foreign medical device manufacturer must appoint a Local Authorized Representative (LAR) that holds a valid BPOM-recognized distribution license—typically an IPAK (Izin Penyalur Alat Kesehatan) or IKD (Izin Distribusi Alat Kesehatan)—covering the product category. The LAR should be familiar with the AKL import medical device registration process, able to manage technical documentation, standard test reports, clinical evaluation where applicable, labeling compliance, and post-market obligations such as adverse event reporting and label change updates.

Published: 2026-07-08 09:00 | Updated: 2026-07-08 09:00

This FAQ covers international medical device registration, documentation preparation, compliance pathways, and post-market maintenance, focusing on the questions companies should prioritize in real projects.

Contents

• Key Summary
• Applicable Scenarios and Core Questions
• Registration Decision Logic
• Core Documents and Evidence
• Common Mistakes
• Company Preparation Checklist
• AIMEILI Perspective
• Frequently Asked Follow-up Questions
• Content Review and Scope of Application

Key Summary

In Indonesia, medical device registration requires appointment of a Local Authorized Representative, usually a company holding a medical device distribution license (IPAK/IKD). When selecting a representative, first confirm that it has BPOM-recognized qualifications, including a valid Izin Penyalur Alat Kesehatan (IPAK) or Izin Distribusi Alat Kesehatan (IKD). The representative should be familiar with the AKL (import medical device registration certificate) application process, especially the registration route corresponding to product classification, such as Class A low-risk and Class B/C medium-to-high-risk. In addition, assess the representative’s technical file handling capability, including whether it can assist with product standard test reports, clinical evaluation (if applicable), and labeling compliance review. It is advisable to choose a representative with successful registration experience for similar products and to sign a contract clearly defining service scope, responsibility allocation, and confidentiality. Avoid selecting solely on low price while ignoring post-market compliance maintenance capabilities, such as adverse event reporting and label change updates. It is generally recommended to obtain recommended representative lists through the Indonesian medical device industry association (Gakeslab) or the BPOM official website.

Applicable Scenarios and Core Questions

When registering medical devices in Indonesia, clients are most concerned about the local representative’s qualification compliance, registration success rate, and ongoing market surveillance support. Specific issues include:

• Whether the representative holds a valid BPOM-recognized distribution license (IPAK/IKD).
• Whether it can efficiently complete product classification confirmation and registration pathway selection.
• Whether it provides full-process services from technical file preparation to label review.
• Whether it has long-term maintenance capability for adverse event reporting and certificate renewal.
• Whether clients can obtain language communication, document translation, and direct liaison with BPOM through the representative.

Registration Decision Logic

When selecting an Indonesian Local Authorized Representative, the following decision logic should be applied:

• First, confirm that the representative has a valid medical device distribution license issued by BPOM and that the license scope covers the type of product to be registered.
• Second, assess whether the representative is familiar with product classification rules, such as risk-based Class A/B/C, and can provide the corresponding registration document checklist.
• Finally, verify whether the representative has the capability to handle technical documents, such as ISO 13485 certificates and clinical evaluation reports, and whether it has effective communication channels with BPOM.
• For high-risk products, such as implantable devices, ensure that the representative has relevant product registration experience.

Core Documents and Evidence

Before selecting a representative, request and verify the following documents:

• Scanned copy of a valid BPOM-issued medical device distribution license (IPAK/IKD).
• Representative’s business license and proof of business scope.
• List of past successful registration cases, including at least three similar products.
• Communication records or recognition documents with BPOM, such as RDA correspondence letters.
• Draft service contract to be signed, including responsibility definition, fee structure, and confidentiality clauses.
• Qualification certificates of the representative’s technical staff, such as medical device regulatory training certificates.

Common Mistakes

Companies often make the following mistakes when selecting an Indonesian representative:

• Failing to verify the validity and category of the representative’s license, leading to rejection of the registration application.
• Choosing based only on price while ignoring the representative’s technical capability and service scope.
• Failing to clarify the representative’s responsibility boundaries, leading to responsibility disputes during registration.
• Ignoring the representative’s support for post-market surveillance, such as reporting and changes.
• Failing to confirm whether the representative holds the distribution category corresponding to the product, such as IKD for Class A and IPAK for Class B/C.

Company Preparation Checklist

Before finalizing a representative, companies should prepare the following materials:

• Product technical documents, including product description, labels, instructions for use, and test reports.
• Quality management system certificate, such as ISO 13485.
• Product risk analysis report and clinical evaluation materials, if required.
• Certificate of registration or free sale certificate from the country of origin.
• Draft Power of Attorney (POA).
• Product samples, if BPOM requires submission for testing.

AIMEILI Perspective

AIMEILI recommends that companies conduct due diligence when selecting a representative and prioritize representatives with industry association backgrounds, such as Gakeslab members, or those recommended by BPOM. The representative contract should clearly define service milestones and deliverables and avoid one-time full payment. For companies entering the Indonesian market for the first time, consider working with a representative that also provides registration consulting and distribution capabilities to simplify supply chain management. Pay close attention to new Indonesian regulatory changes, such as BPOM’s 2023 new requirements for label language, and ensure the representative can respond promptly.

Frequently Asked Follow-up Questions

How can I verify the authenticity of a representative’s license?

You can verify the representative’s license number through BPOM’s online e-Registration query system. You may also request a license verification letter issued by BPOM from the representative or contact BPOM directly for confirmation.

If the representative is replaced mid-process, how is a submitted registration application handled?

According to BPOM rules, changing the representative requires submitting a change application and providing the new representative’s Power of Attorney and license. The original representative must cooperate with the handover. It is advisable to specify the replacement process and cost sharing in the contract.

Continue Reading

Previous: What is the difference between a medical device import license and a registration certificate in Vietnam?

Next: Will incomplete medical device registration documents be returned by Thailand’s TFDA?

Recommended reading:

• What should companies prepare before TGA medical device registration in Australia?
• Can CE documentation be reused for HSA medical device registration in Singapore?
• What core documents are required for MOHAP medical device registration in the UAE?
• Why does ANVISA medical device registration in Brazil take so long?
• What is the difference between a medical device import license and a registration certificate in Vietnam?
• Will incomplete medical device registration documents be returned by Thailand’s TFDA?

Back to FAQ Center | News | Contact AIMEILI

Content Review and Scope of Application

Content author: AIMEILI Regulatory Editorial Team

Professional review: AIMEILI International Medical Device Registration Project Team

Source principles: Priority is given to official regulatory authorities, international organizations, standards organizations, and public regulatory information; industry media and project experience are used only as auxiliary judgment.

Scope of application: This article is intended for preliminary understanding, document preparation, and project planning. It does not replace the formal requirements of the target country’s regulatory authority, testing conclusions, or legal advice.

Compilation note: Compiled from AIMEILI registration practice references, international medical device registration resources, and public regulatory information. Specific projects should be based on the latest requirements of the target country’s regulatory authority and the product documentation.